Depressed youth, suicidality and antidepressants

• 1 Psychological Medicine, University of Sydney, PO Box 142, North Ryde, NSW 1670.
• 2 University of New South Wales, Randwick, NSW.

---

• 1. Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14 857 suicides. Acta Psychiatr Scand 2005; 111: 286-290.<eMJA full text>
• 2. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. BMJ 2005; 330: 385-388.
• 3. Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. JAMA 2004; 292: 807-820.
• 4. Beautrais A. Risk factors for suicide and attempted suicide among young people. Aust N Z J Psychiatry 2000; 34: 420-436.
• 5. Royal Australian and New Zealand College of Psychiatrists, Royal Australian College of General Practitioners and Royal Australasian College of Physicians. Clinical guidance on the use of antidepressant medications in children and adolescents. Available at: http://www.ranzcp.org/publicarea/pracguid.asp (accessed Jun 2005).